GCG and fatty liver disease: However, preclinical studies suggest that Gcg agonism may increaseenergy expenditure and reduce hepatic steatosis, which could indirectly benefitcardiovascular health, albeit with a theoretical risk of increased heart rate andblood pressure [28, 29].